Inscripta 新闻与活动
高管
查看带有其 18 名主要高管的组织结构图
Inscripta 搜索最多的简介
- Sri Kosaraju, Chief Executive Officer and Director
- John Stuelpnagel, Chairman of the Board
- Kristala Prather, Director
创建提醒
跟踪 Inscripta 的高管变动
生物技术
Inscripta 拥有 2,355 家竞争者，其中包括 Incyte (美国(美洲))、Anthos Therapeutics (美国(美洲)) 和 Valneva (法国)。
Popular M&A news in 生物技术
- Ikena Oncology将改名为ImageneBio。 (公布2025七月24号).
- Inmagene Biopharmaceuticals and Ikena Oncology have merged (公布2025七月24号)..
- SAB Biotherapeutics 刚刚宣布为 175 筹款数百万美元。 (公布2025七月22号).
生物技术 行业的其他推荐联系人
消息
Inscripta 的最新新闻稿
- U.S. Government Sets Bold Goals For The U.S. Bioeconomy – Including A Target For 30% Of Bio-Based Chemicals - Inscripta®
- Pressroom - Inscripta®
- U.S. Government Sets Bold Goals For The U.S. Bioeconomy – Including A Target For 30% Of Bio-Based Chemicals - Inscripta®
- BEDOUKIAN RESEARCH INC. PARTNERS WITH INSCRIPTA TO SUSTAINABLY DEVELOP AND MANUFACTURE NATURALLY PRODUCED INGREDIENTS - Inscripta®
- KALSEC® PARTNERS WITH INFINOME™ BIOSCIENCES TO SUSTAINABLY DEVELOP AND MANUFACTURE PRECISION FERMENTATION PRODUCTS - Inscripta®
- News & Events - Inscripta®
- INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING - Inscripta®
- Sestina Bio uses Inscripta’s ONYX® Platform to develop microbial strain ready for scale-up in less than 12 months - Inscripta®
- INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING | Inscripta®
- KALSEC® PARTNERS WITH INFINOME™ BIOSCIENCES TO SUSTAINABLY DEVELOP AND MANUFACTURE PRECISION FERMENTATION PRODUCTS | Inscripta®
- View more press releases Close
